More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

For Kristian Cook, every pizza box he opened was another door closed on the path to overcoming obesity. “I had massive ...

How can we best treat infectious diseases in people with obesity? Hospital pharmacist and Ph.D. researcher Koen van Rhee ...

The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

British patients with obesity undergoing hip and knee replacements had less of a need for subsequent revision when, after surgery, they lost weight by using medications such as GLP-1 receptor agonists ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

In ongoing trials of Eli Lilly’s (LLY) next-generation obesity drug, several trial participants are losing too much weight, STAT’s Elaine Chen ...